Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 USD | 0.00% | -10.00% | +27.66% |
Financials (USD)
Sales 2024 * | 325K | Sales 2025 * | 7.46M | Capitalization | 124M |
---|---|---|---|---|---|
Net income 2024 * | -62M | Net income 2025 * | -60M | EV / Sales 2024 * | 383 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 16.7 x |
P/E ratio 2024 * |
-1.96
x | P/E ratio 2025 * |
-2.3
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.42% |
Latest transcript on aTyr Pharma, Inc.
1 week | -10.00% | ||
Current month | +14.65% | ||
1 month | +14.65% | ||
3 months | -7.22% | ||
6 months | +48.76% | ||
Current year | +27.66% |
Managers | Title | Age | Since |
---|---|---|---|
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 16-03-29 |
Jill Broadfoot
DFI | Director of Finance/CFO | 63 | 18-07-29 |
Lisa Carey
CTO | Chief Tech/Sci/R&D Officer | - | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Schimmel
FOU | Founder | 83 | 05-09-07 |
Tim Coughlin
CHM | Chairman | 57 | 17-04-09 |
John Clarke
BRD | Director/Board Member | 70 | 05-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1.8 | 0.00% | 113,737 |
24-05-23 | 1.8 | -3.23% | 396,244 |
24-05-22 | 1.86 | -4.62% | 292,216 |
24-05-21 | 1.95 | -5.80% | 387,818 |
24-05-20 | 2.07 | +3.50% | 379,354 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.66% | 124M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- LIFE Stock